EcoDrugPlus

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSMMDG00005008875
Gene Symbol: LOC115376177
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSMMDG00005016844
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSMMDG00005014382
Gene Symbol: AVPR1AB
1 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMMDG00005013804
Gene Symbol: AVPR2
1 Cross references
148 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMMDG00005018415
Gene Symbol: AVPR2
1 Cross references
178 Possible Orthologues:

Aromatase

Ensembl ID : ENSMMDG00005008708
Gene Symbol: LOC115355369
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSMMDG00005009187
Gene Symbol: LOC115368257
3 Cross references
193 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMMDG00005010658
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSMMDG00005003446
Gene Symbol: LOC115366053
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSMMDG00005018549
Gene Symbol: LOC115361559
3 Cross references
226 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMMDG00005010531
Gene Symbol: BACE1
1 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSMMDG00005014719
Gene Symbol: BDKRB2
1 Cross references
155 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).